21020 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Porphyrin- or corrin-ring-containing peptides Haemoglobins; Myoglobins
COMPOSITION AND PROCESS FOR A LIPID NANO-PARTICLE DELIVERY OF OXYGEN AND VITAL METABOLIC COMPOUNDS FOR HEMORRHAGIC SHOCK
#2LENTIVIRAL VECTORS EXPRESSING ALPHA-GLOBIN GENES FOR GENE THERAPY OF ALPHA THALASSEMIA
#3PARTICLES COMPRISING PROTEINS ENCAPSULATED IN A POROUS FRAMEWORK AND METHODS OF USING THEREOF
#4Compositions and Methods for Treating Internal Bleeding and Hemorrhage
#5Expression System for Producing a Recombinant Haptoglobin (Hp) Beta Chain
#6ERYTHROPARVOVIRUS WITH A MODIFIED GENOME FOR GENE THERAPY
#7ERYTHROPARVOVIRUS WITH A MODIFIED CAPSID FOR GENE THERAPY
#8SELF-ASSEMBLING OXYGEN CARRIER COMPOSITIONS
#9PROTEIN-ENCLOSING POLYMERIC MICELLE
#10Materials and Methods for Treatment of Hemoglobinopathies
#11COMPOSITIONS, KITS, AND METHODS TO INDUCE ACQUIRED CYTORESISTANCE USING STRESS PROTEIN INDUCERS
#12ADENOSINE DEAMINASE BASE EDITORS AND METHODS FOR USE THEREOF
#13RECOMBINANT LENTIVIRAL VECTOR FOR STEM CELL-BASED GENE THERAPY OF SICKLE CELL DISORDER
#14COMPOSITION INCLUDING MICROBIAL HEMOPROTEIN EXTRACT FOR IMPROVING INTESTINAL FUNCTION AND OBESITY
#15Erythroid Specific Enhancers
#16GENE THERAPY BASED ADMINISTRATION OF LENTIVIRUS VECTOR FOR TREATING HEMOGLOBINOPATHIES
#17A METHOD FOR IN VIVO GENE THERAPY TO CURE SCD WITHOUT MYELOABLATIVE TOXICITY
#18COMPOSITIONS COMPRISING ANIMAL HEMOGLOBIN
#19DIRECT RAAV-MEDIATED IN VIVO GENE EDITING OF HEMATOPOIETIC STEM CELLS
#20GEL BASED ON ANNELID HEMOGLOBIN
#21COMPOSITIONS COMPRISING ANIMAL HEMOGLOBIN
#22Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers
#23METHOD TO ENCAPSULATE AN AQUEOUS SOLUTION COMPRISING A COMPOUND OF INTEREST IN A MATRIX
#24METHODS AND COMPOSITIONS FOR TRANSDUCING HEMATOPOIETIC STEM AND PROGENITOR CELLS IN VIVO
#25SILK PARTICLES ENCAPSULATING OXYGEN CARRIERS AS ARTIFICIAL BLOOD SUBSTITUTE
#26MEDICINE CONTAINING METHEMOGLOBIN ENDOPLASMIC RETICULUM AS ACTIVE INGREDIENT AND USE THEREOF
#27METHOD FOR ACTIVATING EXPRESSION OF GAMMA-GLOBIN GENE, AND COMPOSITION
#28Compositions and Methods for Treating Hemorrhagic Shock
#29CAPSID-MODIFIED RAAV VECTOR COMPOSITIONS AND METHODS THEREFOR
#30BLOOD SUBSTITUTES COMPRISING HEMOGLOBIN AND METHOGS OF MAKING
#31NITROXYLATED PROTEINS AND METHODS FOR THE USE THEREOF
#32Hemoglobin Substitute Mixtures Including Reconstituted Plasma and Platelets and Their Manufacture and Use
#33HEMOGLOBIN-BASED NANOPARTICLES FOR OXYGEN DELIVERY
#34Thiosuccinyl-crosslinked hemoglobin conjugates and methods of use and preparation thereof
#35COMPOSITIONS AND METHODS FOR TREATING ALPHA THALASSEMIA
#36PROTEIN-ENCLOSING POLYMERIC MICELLE
#37Anti-Bacterial Combination Therapy
#38Use of neuroglobin agonist for preventing or treating mitochondrial RCCI and/or RCCIII deficiency disease
#39Hemoglobin derivative co-conjugated with fatty acid-linked PEG and alkoxy PEG as a blood substitute
#40Oxygen carriers for the treatment of skin indispositions
#41Modified globin proteins
#42Self-assembling oxygen carrier compositions
#43SYNTHESIS AND STRUCTURE OF HIGH POTENCY RNA THERAPEUTICS
#44MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES
#45Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers
#46Method and compositions for protecting tissue
#47Reduced oxygen carriers and their use for the treatment of carboxyhemoglobinemia
#48FOOD FACTOR-BASED FORMULATION, PRODUCTS PRODUCED USING SAID FORMULATION AND METHODS FOR PRODUCING SAME
#49Annelid haemoglobin lyophilisation process
#50USE OF HEMOGLOBIN FROM ANNELIDS AS BACTERICIDE, IN PARTICULAR FOR PREVENTING AND/OR TREATING A PERIODONTAL DISEASE
#51Materials and methods for treatment of hemoglobinopathies
#52Therapeutic retroviral vectors for gene therapy
#53COMPOSITIONS AND METHODS FOR INDUCING NANOPARTICLE-MEDIATED MICROVASCULAR EMBOLIZATION FOR TUMORS
#54Scarring reducing wound treatment
#55Compositions and methods for treatment of cancer
#56Wound spray
#57Blood substitutes comprising hemoglobin and methods of making
#58Lentiviral vector for treating hemoglobin disorders
#59Recombinant lentiviral vector for stem cell- based gene therapy of sickle cell disorder
#60COMPOSITIONS AND METHODS FOR INDUCING NANOPARTICLE-MEDIATED MICROVASCULAR EMBOLIZATION OF TUMORS
#61Methods for treatment of nephrotic syndrome and related conditions
#62Generation of hemoglobin-based oxygen carriers using elastin-like polypeptides
#63Pulse wave detection device, image analysis device, and biometric information generation system
#64Microparticles
#65Hemoglobin based oxygen carrier and method of preparation
#66Compositions and methods for improved encapsulation of functional proteins in polymeric vesicles
#67Composition and methods for treating ischemic wounds and inflammatory conditions
#68COMPOSITIONS AND METHODS FOR INDUCING NANOPARTICLE-MEDIATED MICROVASCULAR EMBOLIZATION FOR TUMORS
#69REDUCTION OF LIPASE ACTIVITY IN PRODUCT FORMULATIONS
#70COMPOSITIONS, KITS, AND METHODS TO INDUCE ACQUIRED CYTORESISTANCE USING STRESS PROTEIN INDUCERS
#71Reduced oxygen carriers and their use for the treatment of carboxyhemoglobinemia
#72Microparticles
#73Immunostimulant
#74POLYMERIC RED BLOOD CELL-LIKE PARTICLES
#75Succinimide-activated nitroxyl compounds and methods for the use thereof for nitroxylation of proteins
#76CAPSID-MODIFIED RAAV VECTOR COMPOSITIONS AND METHODS THEREFOR
#77Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers
#78Artificial Red Blood Cell Having Ability to Inhibit Conversion of Hemoglobin into Methemoglobin
#79Activated polyoxazolines and conjugates and compositions comprising the same
#80Technology for the Preparation of Microparticles
#81Therapeutic retroviral vectors for gene therapy
#82GENERATION OF HEMOGLOBIN-BASED OXYGEN CARRIERS USING ELASTIN LIKE POLYPEPTIDES
#83Capsid-modified rAAV vector compositions and methods therefor
#84Synthesis and structure of high potency RNA therapeutics
#85Hemoglobin compositions
#86Method of ameliorating side effects of sickle cell disease treatments
#87Diagnosis and treatment of preeclampsia
#88Reduction of lipase activity in product formulations
#89AAV vectors with high transduction efficiency and uses thereof for gene therapy
#90Technology for the Preparation of Microparticles
#91Materials and methods for treatment of hemoglobinopathies
#92Use of PLL for improving the stability of molecules in solution
#93Composition and methods for treating ischemic wounds and inflammatory conditions
#94Compositions and Methods for Inducing Nanoparticle Mediated Microvascular Embolization of Tumors
#95COMPOSITIONS AND METHODS FOR INDUCING NANOPARTICLE-MEDIATED MICROVASCULAR EMBOLIZATION OF TUMORS
#96METHOD OF ISOLATING CELLS FROM A TISSUE IN A MAMMAL
#97Conjugated Proteins
#98USE OF HEMOGLOBIN EFFECTORS TO INCREASE THE BIOAVAILABILITY OF THERAPEUTIC GASES
#99Compositions and methods for the treatment of phenylketonuria (PKU)
#100Treatment of cancer and inhibition of metastasis using hemoglobin beta subunit
#101Lentiviral vector for treating hemoglobin disorders
#102Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imaging
#103Enteric-coated hemoglobin multiparticulate for oral delivery of hemoglobin based oxygen carriers
#104Activated polyoxazolines and conjugates and compositions comprising the same
#105Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers
#106BIODEGRADABLE NANOPARTICLES AS NOVEL HEMOGLOBIN-BASED OXYGEN CARRIERS AND METHODS OF USING THE SAME
#107Hemoglobin compositions
#108Bioerodible silicon-based compositions for delivery of therapeutic agents
#109Compositions and methods for improved encapsulation of functional proteins in polymeric vesicles
#110Oral delivery system for hemoglobin based oxygen carriers
#111Methods for treatment of nephrotic syndrome and related conditions
#112Blood substitute composition and method of use
#113Reduction of lipase activity in product formulations
#114MICROPARTICLES, BLOOD SUBSTITUTE AND METHOD FOR FORMING SAME
#115Nanoparticle fabrication methods, systems, and materials for fabricating artificial red blood cells
#116Implantable preparations for regeneration of tissues and treatment of wounds, their method of preparation, and method of treatment of patients with said implantable preparations
#117Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers
#118PROTEIN-SPECIFIC FORMULATIONS
#119Technology for the Preparation of Microparticles
#120Wound spray
#121NOVEL HEMOGLOBIN-DERIVED PEPTIDE BASED PHARMACEUTICAL COMPOSITIONS
#122Use of nutritional supplement for increasing the bacterial mass in the rumen of a ruminant
#123Use of a hemoglobin for the preparation of dressings and resulting dressings
#124Scarring reducing wound treatment
#125Pegylated Hemoglobin and Albumin and Uses Thereof
#126Hemostatic compositions
#127Blood substitute composition and method of use
#128Therapeutic retroviral vectors for gene therapy
#129Polyalkylene oxide valerate hemoglobin conjugates
#130Pharmaceutical composition comprising recombinant hemoglobin protein or subunit-based therapeutic agent for cancer targeting treatment
#131USE OF HAEMOGLOBIN OF ANNELIDS FOR TREATING CANCER
#132Technology for the Preparation of Microparticles
#133Method and apparatus for continuous removal of sub-micron sized particles in a closed loop liquid flow system
#134Oral delivery for hemoglobin based oxygen carriers
#135Pharmaceutical composition for treating medical conditions and a method for treating alimentary disorders and related diseases
#136Synthesis of oxygen carrying, turbulence resistant, high density submicron particulates
#137Diaspirin crosslinked pegylated hemoglobin
#138Compositions for improved tissue oxygenation by peritoneal ventilation
#139Hemoglobin compositions
#140Method of enhancing efficacy of blood transfusions
#141Methods of preparing cells and compositions
#142SCARRING REDUCING WOUND TREATMENT
#143Capsid-modified rAAV vector compositions and methods therefor
#144Biodegradable nanoparticles as novel hemoglobin-based oxygen carriers and methods of using the same
#145Biodegradable nanoparticles as novel hemoglobin-based oxygen carriers and methods of using the same
#146Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imaging
#147Hemoglobin-based oxygen carrier-containing pharmaceutical composition for cancer targeting treatment and prevention of cancer recurrence
#148Bioerodible silicon-based compositions for delivery of therapeutic agents
#149Wound spray
#150Polyionic dendrimer and hydrogel comprising same
#151HEMOGLOBIN-CONTAINING LIPOSOME AND METHOD FOR PRODUCING SAME
#152Methods for treatment of nephrotic syndrome and related conditions
#153Use of an agent that restores tissue perfusion and oxygenation
#154CARBIDE-DERIVED-CARBON-BASED OXYGEN CARRIERS
#155Use of liver growth factor (LGF) as a neural tissue regenerator
#156Use of extracellular hemoglobin obtained from the marine worm, , for the preservation of organs, tissues, cells
#157HEMOGLOBIN-BASED OXYGEN CARRIER-CONTAINING PHARMACEUTICAL COMPOSITION FOR CANCER TARGETING TREATMENT AND PREVENTION OF CANCER RECURRENCE
#158Hemoglobin compositions
#159Nanoparticle fabrication methods, systems, and materials for fabricating artificial red blood cells
#160Method of isolating cells from a tissue in a mammal
#161Methods for increasing plasmin activity and promoting plaque regression in the treatment of atherosclerosis
#162Blood substitutes and uses thereof
#163Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
#164Method of enhancing efficacy of blood transfusions
#165COMPOSITIONS FOR OXYGEN TRANSPORT COMPRISING A HIGH OXYGEN AFFINITY MODIFIED HEMOGLOBIN
#166Oral delivery for hemoglobin based oxygen carriers
#167METHOD FOR THE PREPARATION OF A HEAT STABLE OXYGEN CARRIER-CONTAINING COMPOSITION FACILATING BETA-BETA CROSS-LINKING
#168METHOD OF DELIVERING OXYGEN USING PEG-HEMOGLOBIN CONJUGATES WITH ENHANCED NITRITE REDUCTASE ACTIVITY
#169Use of an agent that restores tissue perfusion and oxygenation
#170NITRIC OXIDE-BLOCKED CROSS-LINKED TETRAMERIC HEMOGLOBIN
#171Sickled erythrocytes with anti-tumor agents induce tumor vaso-occlusion and tumoricidal effects
#172NOVEL METHOD FOR TREATMENT OF SKIN WOUNDS AND PREPARATIONS FOR IMPLEMENTATION OF SAME
#173Synthesis Of Oxygen Carrying, Turbulence Resistant, High Density Submicron Particulates
#174Technology for the Preparation of Microparticles
#175POLYIONIC DENDRIMER AND HYDROGEL COMPRISING SAME
#176MalPEG Hb conjugate-containing compositions for delivering nitric oxide (NO) to cells
#177MalPEG-Hb conjugate-containing compositions for delivering carbon monoxide (CO) to cells
#178Method And Apparatus For Continuous Removal Of Submicron Sized Particles In A Closed Loop Liquid Flow System
#179COMPOSITION AND PROCESS FOR SYNTHESIZING TENSE AND RELAXED STATE POLYMERIZED HEMOGLOBIN
#180Therapeutic retroviral vectors for gene therapy
#181Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
#182METHOD FOR THE PREPARATION OF A HEAT STABLE OXYGEN CARRIER-CONTAINING PHARMACEUTICAL COMPOSITIONS AND THE USE THEREOF
#183TREATMENT METHODS USING A HEAT STABLE OXYGEN CARRIER-CONTAINING PHARMACEUTICAL COMPOSITION
#184Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof
#185THERAPEUTIC RETROVIRAL VECTORS FOR GENE THERAPY
#186Biodegradable nanoparticles as novel hemoglobin-based oxygen carriers and methods of using the same
#187Polymerized Hemoglobin Media And Its Use In Isolation And Transplantation of Islet Cells
#188Carbide-derived-carbon-based oxygen carriers
#189Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells
#190Antimicrobial Composition and Method for Use
#191SUPPRESSION OF ALLERGIC INFLAMMATION BY ASCARIS HEME-BINDING PROTEIN (HBP)
#192Five-coordinate neuroglobin and use thereof as a blood substitute
#193Hemoglobin compositions
#194Use of an agent that restores tissue perfusion and oxygenation
#195Use of a haemoglobin for the preparation of dressings and resulting dressings
#196Use of a high molecular weight extracellular hemoglobin for the manufacture of a medicament for treating and/or preventing diseases by inhibition of calcium
#197Second generation low oxygen affinity pegylated hemoglobins as oxygen-carrying plasma expanders
#198Use of a globin, a globin protomer or an extracellular hemoglobin obtained from the marine worm, , for the preservation of organs, tissues, cells or cell cultures
#199TARGETED OXYGEN DELIVERY VIA INTRAVENOUS OR INTRA-ARTERIAL INFUSION OF OXYGENATED POLYMERIZED HEMOGLOBIN SOLUTIONS
#200Micro-particles, blood-substitute and method for forming same
#201Method and Apparatus for Preparing an Acellular Red Blood Cell Substitute
#202OXYGEN-CARRYING BLOOD SUBSTITUTE PREPARATIONS
#203Novel combinatorial approaches to enhancing oxygen transport to tissues
#204Lyophilization of Hemoglobin Solutions
#205Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
#206Diagnosis and treatment of preeclampsia
#207Method to enhance hemodynamic stability using oxygen carrying compositions
#208S-Nitrosothiols Containing Composition for the Treatment of Fatty Liver Diseases, Obesity and Other Diseases Associated with the Metabolic Syndrome and the Use of Such Compositions
#209Attenuation of vasoactive oxygen carrier-induced vasoconstriction
#210HEMOGLOBIN ALPHA CHAIN PEPTIDE FRAGMENTS USEFUL FOR INHIBITING STEM CELL PROLIFERATION
#211METHODS AND COMPOSITIONS FOR THE TOPICAL OXYGENATION OF HYPOXIC TISSUE
#212Nitric oxide-blocked cross-linked tetrameric hemoglobin
#213Nanoparticle fabrication methods, systems, and materials for fabricating artificial red blood cells
#214Preparation, for use, in particular, for tissue augmentation and healing
#215SCREENING METHOD TO IDENTIFY PROTECTIVE SUBSTANCES FOR THE TREATMENT OF NEURODEGENERATIVE AND/OR ISCHAEMIC DISEASES
#216Pegylated albumin and uses thereof
#217Composition and method for treating iron deficiency anemia
#218Method for determining physiological effects of hemoglobin
#219MEDICAL ARTICLES FOR THE TREATMENT OF TUMORS
#220Technology for the Preparation of Microparticles
#221MalPEG-Hb conjugate- containing compositions for delivering carbon monoxide (CO) to cells
#222Method to enhance hemodynamic stability using oxygen carrying compositions
#223IMPLANTABLE PREPARATIONS COMPRISING GLOBIN, PROCESS FOR THEIR PRODUCTION, AND USES
#224Alternate morpheein forms of allosteric proteins as a target for the development of bioactive molecules
#225Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells
#226Biological Tissue Examination Agent Comprising Hemoglobin Labeled With Oxygen Isotope And Method For Producing The Same
#227Physiologically acceptable aqueous solutions and methods for their use
#228OXYGEN-CARRYING BLOOD SUBSTITUTE PREPARATIONS
#229ELICITING IMPROVED IMMUNE RESPONSES
#230Use of Haptoglobin and Hemoglobin to Modulate Na Ion Transport in a Vertebrate
#231METHODS AND COMPOSITIONS FOR REDUCING THE RISK OF ADVERSE CARDIOVASCULAR EVENTS ASSOCIATED WITH THE ADMINISTRATION OF ARTIFICIAL BLOOD
#232Use of an agent that restores tissue perfusion and oxygenation
#233Method and apparatus for preparing an acellular red blood cell substitute
#234Method of inhibiting side effects of pharmaceutical compositions containing amphiphilic vehicles or drug carrier molecules
#235Use of an agent that restores tissue perfusion and oxygenation
#236Nitric oxide-blocked cross-linked tetrameric hemoglobin
#237Virus-Inactivated Hemoglobin And Method Of Producing The Same
#238Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components
#239Methods of treating acute blood loss
#240Multifunctional blood substitute
#241Pharmaceutical combined preparation containing a therapeutic protein
#242Polymerized Hemoglobin Media and its Use in Isolation and Transplantation of Islet Cells
#243Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
#244Stabilized hemoglobin solutions
#245Method for making a high oxygen affinity modified hemoglobin for oxygen transport
#246Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination
#247Hemoglobin conjugates
#248Gels for encapsulation of biological materials
#249Composition and method for treating iron deficiency anemia
#250Use of hyperpolymeric hemoglobin for the treatment of pulmonary edema
#251Implantable preparations
#252Reduction in myocardial infarction size
#253Polymerized hemoglobin solutions having reduced amounts of tetramer and method for preparing
#254Use of an agent that restores tissue perfusion and oxygenation
#255Capillary membrane stabilization and reduction of tissue injury through use of biodegradable macromolecules with antioxidants and/or other chemicals
#256Method of removing carbon monoxide from an oxygen carrier and apparatus for removing carbon monoxide
#257Hemoglobin conjugate and the preparation method and its use
#258Compositions and methods for delivering carbon monoxide (CO) and nitric oxide (NO) to tissue using heme proteins as carriers
#259Nitrosated and nitrosylated heme proteins
#260Materials, methods, and devices for treatment of arthropathies and spondylopathies
#261Copolymer and hemoprotein based novel compounds and uses thereof
#262Methods to enhance hemodynamic stability using oxygen carrying compositions
#263Preserving a hemoglobin blood substitute with a transparent overwrap
#264Oxygenating agents for enhancing host responses to microbial infections
#265Artificial oxygen carrier containing preventive agents of metHb formation
#266Use of defibrinated blood for manufacture of hemoglobin-based oxygen carrier
#267Therapeutic retroviral vectors for gene therapy
#268Method of skin care and/or treatment using rice (Oryza sativa) hemoglobin or other hexacoordinated, non-symbiotic plant hemoglobins
#269Stabilized hemoglobin solutions
#270Antimicrobial composition and method for use
#271Methods and compositions for optimization of oxygen transport by cell-free systems
#272Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders
#273Pharmaceutical combination preparations containing erythropoietin and modified haemoglobins
#274Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
#275Use of one or more natural or modified oxygen carriers, devoid of plasma and cellular membrane constiuents, for externally treating open, in particular chronic wounds
#276Biodegradable polymeric nanocapsules and uses thereof
#277Medical use of reuterin
#278Methods and compositions for oxygen transport comprising an oxygen carrier and a crystalloid in hypertonic solution
#279Method for improving oxygen transport by stored red blood cells
#280Method and apparatus for preparing an acellular red blood cell substitute
#281Inhibitor of stem cell proliferation and uses thereof
#282Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
#283Oxygen carrier system, artificial oxygen carrier, and reducing agent
#284Methods and compositions for oxygen transport comprising modified hemoglobin in plasma
#285Methods and compositions for optimization of oxygen transport by cell-free systems